Levothyroxine Sodium Oral Solution to Control Thyroid Function in a Patient with Hypothyroidism and Celiac Disease

Overview

Journal Clin Case Rep

Date 2021 Jun 7

PMID 34094556

Citations 5

Authors

Ernest Asamoah

Affiliations

Soon will be listed here.

Abstract

Implementing a gluten-free diet and switching to the levothyroxine oral solution significantly improved malabsorptive and hypothyroid symptoms in a patient with hypothyroidism, Addison's disease, and celiac disease without the need to increase levothyroxine dosage.

Citing Articles

Switching from Natural Desiccated Thyroid to a Liquid Formulation of Levothyroxine for Hypothyroidism.

Khoshaba L, Patarkatsi L Case Rep Endocrinol. 2024; 2023:4252894.

PMID: 38179415 PMC: 10766474. DOI: 10.1155/2023/4252894.

Levothyroxine: Conventional and Novel Drug Delivery Formulations.

Liu H, Li W, Zhang W, Sun S, Chen C Endocr Rev. 2022; 44(3):393-416.

PMID: 36412275 PMC: 10166268. DOI: 10.1210/endrev/bnac030.

New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.

Bugala N, Carsote M, Stoica L, Albulescu D, Tuculina M, Preda S Diagnostics (Basel). 2022; 12(9).

PMID: 36140482 PMC: 9497746. DOI: 10.3390/diagnostics12092080.

What about TSH and Anti-Thyroid Antibodies in Patients with Autoimmune Thyroiditis and Celiac Disease Using a Gluten-Free Diet? A Systematic Review.

Malandrini S, Trimboli P, Guzzaloni G, Virili C, Lucchini B Nutrients. 2022; 14(8).

PMID: 35458242 PMC: 9028602. DOI: 10.3390/nu14081681.

Levothyroxine sodium oral solution to control thyroid function in a patient with hypothyroidism and celiac disease.

Asamoah E Clin Case Rep. 2021; 9(5):e04170.

PMID: 34094556 PMC: 8163109. DOI: 10.1002/ccr3.4170.

References

Yue C, Scarsi C, Ducharme M . Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12):631-6. DOI: 10.1055/s-0032-1329951. View

McMillan M, Rotenberg K, Vora K, Sterman A, Thevathasan L, Ryan M . Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project. Drugs R D. 2015; 16(1):53-68. PMC: 4767717. DOI: 10.1007/s40268-015-0116-6. View

Lerner A, Jeremias P, Matthias T . Gut-thyroid axis and celiac disease. Endocr Connect. 2017; 6(4):R52-R58. PMC: 5435852. DOI: 10.1530/EC-17-0021. View

Pabla D, Akhlaghi F, Zia H . A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm. 2008; 72(1):105-10. DOI: 10.1016/j.ejpb.2008.10.008. View

Ramadhan A, Tamilia M . Treatment-refractory hypothyroidism. CMAJ. 2011; 184(2):205-9. PMC: 3273508. DOI: 10.1503/cmaj.110994. View

Ruchala M, Szczepanek-Parulska E, Zybek A . The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endokrynol Pol. 2012; 63(4):318-23. View

Virili C, Giovanella L, Fallahi P, Antonelli A, Santaguida M, Centanni M . Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2018; 9:10. PMC: 5790785. DOI: 10.3389/fendo.2018.00010. View

Asamoah E . Levothyroxine sodium oral solution to control thyroid function in a patient with hypothyroidism and celiac disease. Clin Case Rep. 2021; 9(5):e04170. PMC: 8163109. DOI: 10.1002/ccr3.4170. View

Antonelli A, Benvenga S . Editorial: The Association of Other Autoimmune Diseases in Patients With Thyroid Autoimmunity. Front Endocrinol (Lausanne). 2018; 9:540. PMC: 6146093. DOI: 10.3389/fendo.2018.00540. View

10.

Fallahi P, Ferrari S, Ruffilli I, Ragusa F, Biricotti M, Materazzi G . Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update. Expert Opin Drug Deliv. 2016; 14(5):647-655. DOI: 10.1080/17425247.2016.1227782. View

11.

Boelaert K, Newby P, Simmonds M, Holder R, Carr-Smith J, Heward J . Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010; 123(2):183.e1-9. DOI: 10.1016/j.amjmed.2009.06.030. View

12.

Virili C, Bassotti G, Santaguida M, Iuorio R, Del Duca S, Mercuri V . Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 2012; 97(3):E419-22. DOI: 10.1210/jc.2011-1851. View

13.

Centanni M, Benvenga S, Sachmechi I . Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report. J Endocrinol Invest. 2017; 40(12):1289-1301. PMC: 5680379. DOI: 10.1007/s40618-017-0706-y. View